Menu
  • Join
  • Login
  • Contact
 

Search abstracts


Pharmacogenetics in Type 2 Diabetes Treatment.

  • At: 2012 FIP Congress in Amsterdam (the Netherlands)
  • Type: Poster
  • By: SEMIZ, Sabina (University of Sarajevo, Faculty of Pharmacy, Sarajevo, Bosnia and Herzegovina)
  • Co-author(s): Dujic, T. (University of Sarajevo, Sarajevo, Bosnia and Herzegovina)
    Causevic-Ramosevac, A. (Bosnalijek, Sarajevo, Bosnia and Herzegovina)
    Causevic, A. (University of Sarajevo, Sarajevo, Bosnia and Herzegovina)
  • Abstract:

    Background: Type 2 diabetes (T2D) is a worldwide epidemic with considerable health and economic consequences. Diabetic patients are often treated with more than one oral antidiabetic drug (OAD), including metformin and sulfonylureas (SU). Genetic variations in drug-metabolizing enzymes (DME), drug-transporters (DT), and other specific drug targets

    ..

  • The access to the whole abstract and the presentation file is available to FIP members and to congress participants of that specific congress. Please login
Last update 4 October 2019

FIP Congresses